Text Size

Extravascular Lung Water Index in Severe Sepsis (EVLI in sepsis)

This study has been completed.
Sponsor:
Information provided by:
Chang Gung Memorial Hospital
ClinicalTrials.gov Identifier:
NCT00986271
First received: September 27, 2009
Last updated: September 28, 2009
Last verified: April 2008
History of Changes
  Purpose

To investigate whether extravascular lung water index (EVLI) is an independent predictor for multiorgan dysfunction syndrome (MODS) in patients with severe sepsis and to determine if increased EVLI may serve as an predictor for MODS and mortality in those patients.


Condition Intervention
Severe Sepsis
 Procedure: EVLI was determinated by PiCCO plus system.

Study Type: Interventional
Study Design: Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Diagnostic

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Chang Gung Memorial Hospital:

Primary Outcome Measures:
  • Developement of MODS (multiorgan dysfunction syndrome) and mortality

Enrollment: 67
Arms Assigned Interventions
With and without MODS developement
EVLI was determinated by PiCCO plus system.
 Procedure: EVLI was determinated by PiCCO plus system.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • All enrolled patients were recruited consecutively on the day of MICU admission and within 24 hours of the diagnosis of severe sepsis.

Exclusion Criteria:

  • Pregnancy,
  • Age less than 18 years old, and
  • Uncontrolled malignancy.
  Contacts and Locations
No Contacts or Locations Provided
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00986271     History of Changes
Other Study ID Numbers: 97-0374B
Study First Received: September 27, 2009
Last Updated: September 28, 2009
Health Authority: Taiwan: Institutional Review Board

Keywords provided by Chang Gung Memorial Hospital:
severe sepsis, intensive care units

Additional relevant MeSH terms:
Sepsis
Toxemia
Infection
 Systemic Inflammatory Response Syndrome
Inflammation
Pathologic Processes

ClinicalTrials.gov processed this record on May 22, 2013